Formycon AG
General
Total Cases5
Active Cases5
Patents2
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/29/25 | USCA for the FEDERAL CIRCUIT JUDGMENT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG. (snc) (Entered: 01/29/2025) | |
| 01/29/25 | OPINION of USCA for the FEDERAL CIRCUIT as to (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG USCA Decision: AFFIRMED. (snc) (Entered: 01/29/2025) | |
| 01/29/25 | USCA JUDGMENT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD.,, (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. (snc) (Entered: 01/29/2025) | |
| 01/29/25 | OPINION of USCA for the FEDERAL CIRCUIT as to (344 in 1:24-md-03103-TSK-JPM, 258 in 1:24-cv-00039-TSK-JPM) Notice of Appeal filed by Regeneron Pharmaceuticals, Inc., (250 in 1:23-cv-00106-TSK-JPM, 259 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Samsung Bioepis Co., Ltd., (801 in 1:22-cv-00061-TSK-JPM, 190 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., (269 in 1:24-md-03103-TSK-JPM, 204 in 1:23-cv-00089-TSK-JPM) Notice of Appeal, filed by Celltrion, Inc., (258 in 1:24-md-03103-TSK-JPM, 268 in 1:23-cv-00094-TSK-JPM) Notice of Appeal filed by Samsung Bioepis, CO., LTD., (244 in 1:23-cv-00094-TSK-JPM, 175 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis, CO., LTD.,, (242 in 1:23-cv-00097-TSK-JPM, 203 in 1:24-md-03103-TSK-JPM) Notice of Appeal, filed by Formycon AG, (254 in 1:23-cv-00097-TSK-JPM, 261 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Formycon AG, (176 in 1:24-md-03103-TSK-JPM, 226 in 1:23-cv-00106-TSK-JPM) Notice of Appeal, filed by Samsung Bioepis Co., Ltd., (198 in 1:23-cv-00089-TSK-JPM, 241 in 1:24-md-03103-TSK-JPM) Notice of Appeal filed by Celltrion, Inc. USCA for the FEDERAL CIRCUIT Decision: AFFIRMED. (snc) (Entered: 01/29/2025) | |
| 01/23/25 | Other Document PLAINTIFF REGENERON PHARMACEUTICALS, INC.'S ANSWER TO DEFENDANT FORMYCON AG'S COUNTERCLAIMS filed by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 01/23/2025) | |
| 01/07/25 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 452 , 454 , 455 . Signed by Chief District Judge Thomas S. Kleeh on 01/07/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 01/07/2025) | |
| 01/02/25 | MOTION for Leave to File Under Seal by Formycon AG. (Attachments: # [1] Exhibit A, # [2] Memorandum in Support of Defendant's Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 01/02/2025) | |
| 12/13/24 | ORDER GRANTING MOTIONS FOR LEAVE TO FILE UNDER SEAL. The following motions to seal are GRANTED: ECF Nos. 440 , 442 , 444 . Signed by Chief District Judge Thomas S. Kleeh on 12/13/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 12/13/2024) | |
| 12/12/24 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # [1] Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Pogue, David) (Entered: 12/12/2024) | |
| 12/12/24 | ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. 426 , 427 , 438 . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. 429 , 431 . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) |